Functional implications of CD34 expression in human adipose-derived stem/progenitor cells

Stem Cells and Development

Volumn 18, Issue 8, 2009, Pages 1201-1209

  Suga, Hirotaka ^a   Matsumoto, Daisuke ^a   Eto, Hitomi ^a   Inoue, Keita ^a   Aoi, Noriyuki ^a   Kato, Harunosuke ^a   Araki, Jun ^a   Yoshimura, Kotaro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN RECEPTOR; CD146 ANTIGEN; CD34 ANTIGEN; GROWTH FACTOR; SCATTER FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADIPOCYTE; ADULT; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BIOLOGY; BONE; CAPILLARY; CD34 SELECTION; CELL DIFFERENTIATION; CELL DIVISION; CELL FRACTIONATION; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FAT BODY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN EXPERIMENT; HYPOXIA; NORMAL HUMAN; OSTEOBLAST; PERICYTE; PHYSIOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE; STEM CELL;

ADIPOCYTES; ADULT; ANTIGENS, CD34; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOVEMENT; CELL SEPARATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS;

EID: 67650811823     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0003     Document Type: Article

References (37)

1. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.
2. Rodriguez AM, C Elabd, EZ Amri, G Ailhaud and C Dani. (2005). The human adipose tissue is a source of multipotent stem cells. Biochimie 87:125-128.
3. Zheng B, B Cao, G Li and J Huard. (2006). Mouse adiposederived stem cells undergo multilineage differentiation in vitro but primarily osteogenic and chondrogenic differentiation in vivo. Tissue Eng 12:1891-1901.
4. Katz AJ, R Llull, MH Hedrick and JW Futrell. (1999). Emerging approaches to the tissue engineering of fat. Clin Plast Surg 26:587-603.
5. Gimble JM, AJ Katz and BA Bunnell. (2007). Adipose-derived stem cells for regenerative medicine. Circ Res 100:1249-1260.
6. Yoshimura K, T Shigeura, D Matsumoto, T Sato, Y Takaki, E Aiba-Kojima, K Sato, K Inoue, T Nagase, I Koshima and K Gonda. (2006). Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 208:64-76.
7. Gronthos S, DM Franklin, HA Leddy, PG Robey, RW Storms and JM Gimble. (2001). Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189:54-63.
8. Mitchell JB, K McIntosh, S Zvonic, S Garrett, ZE Floyd, A Kloster, YD Halvorsen, RW Storms, B Goh, G Kilroy, X Wu and JM Gimble. (2006). Immunophenotype of human adiposederived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24:376-385.
9. Traktuev DO, S Merfeld-Clauss, J Li, M Kolonin, W Arap, R Pasqualini, BH Johnstone, and KL March. (2008). A population of multipotent CD34-positive adipose stromal cells share pericytic and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 102:77-85.
10. Spalding KL, E Arner, PO Westermark, S Bernard, BA Buchholz, O Bergmann, L Blomqvist, J Hoffstedt, E Näslund, T Britton, H Concha, M Hassan, M Rydén, J Frisén and P Arner (2008). Dynamics of fat cell turnover in humans. Nature 453:783-787.
11. Tang W, D Zeve, JM Suh, D Bosnakovski, M Kyba, RE Hammer, MD Tallquist and JM Graff. (2008). White fat progenitor cells reside in the adipose vasculature. Science 322:583-586.
12. Rodeheffer MS, K Birsoy and JM Friedman. (2008). Identifi cation of white adipocytes progenitor cells in vivo. Cell 135:240-249.
13. Suga H, T Shigeura, D Matsumoto, K Inoue, H Kato, N Aoi, S Murase, K Sato, K Gonda, I Koshima and K Yoshimura. (2007). Rapid expansion of human adipose-derived stromal cells preserving multipotency. Cytotherapy 9:738-745.
14. Balwierz A, U Czech, A Polus, RK Filipkowski, B Mioduszewska, T Proszynski, P Kolodziejczyk, J Skrzeczynska-Moncznik, W Dudek, L Kaczmarek, J Kulig, J Pryjma and A Dembinska-Kiec. (2008). Human adipose tissue stromal vascular fraction cells differentiate depending on distinct types of media. Cell Prolif 41:441-459.
15. Nakagami H, K Maeda, R Morishita, S Iguchi, T Nishikawa, Y Takami, Y Kikuchi, Y Saito, K Tamai, T Ogihara, Y Kaneda. (2005). Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol. 25:2542-2547.
16. Civin CI, LC Strauss, C Brovall, MJ Fackler, JF Schwartz and JH Shaper. (1984). Antigenic analysis of hematopoiesis III. A hematopoietic progenitor cell surface antigen defi ned by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157-165.
17. Berenson RJ, RG Andrews, WI Bensinger, D Kalamasz and G Knitter. (1998). Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951-955.
18. Krause DS, MJ Fackler, CI Civin and WS May. (1996). CD34: structure, biology, and clinical utility. Blood 87:1-13.
19. Suster S and C Fisher. (1997). Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors. Am J Surg Pathol 21:195-200.
20. Lange C, Z Li, L Fang, C Baum and B Fehse. (2007). CD34 modulates the traffi cking behavior of hematopoietic cells in vivo. Stem Cells Dev 16:297-304.
21. Sato T, JH Laver and M Ogawa. (1999). Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94:2548-2554.
22. Dao MA, J Arevalo and JA Nolta. (2003). Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 101:112-118.
23. Goodel MA. (1999). CD34+ or CD34-: does it really matter? Blood 94:2545-2547.
24. Suga H, H Eto, T Shigeura, K Inoue, N Aoi, H Kato, S Nishimura, I Manabe, K Gonda and K Yoshimura. (2009). IFATS collection: fibroblast growth factor-2-induced hepatocyte growth factor secretion by adipose-derived stromal cells inhibits postinjury fi brogenesis through a c-Jun N-terminal kinase-dependent mechanism. Stem Cells 27:238-249.
25. Quarto N and MT Longaker. (2006). FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 12:1405-1418.
26. Kakudo N, A Shimotsuma and K Kusumoto. (2007). fibroblast growth factor-2 stimulates adipogenic differentiation of human adipose-derived stem cells. Biochem Biophys Res Commun 359:239-244.
27. Xu Y, P Malladi, M Chiou, E Bekerman, AJ Giaccia and MT Longaker. (2007). In Vitro expansion of adipose-derived adult stromal cells in hypoxia enhances early chondrogenesis. Tissue Eng 13:2981-2993. (Pubitemid 350233076)
28. Katz AJ, A Tholpady, SS Tholpady, H Shang and RY Ogle. (2005). Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23:412-423.
29. Aiba-Kojima E, NH Tsuno, K Inoue, D Matsumoto, T Shigeura, T Sato, H Suga, H Kato, T Nagase, K Gonda, I Koshima and K Yoshimura. (2007). Characterization of wound drainage fluids as a source of soluble factors associated with wound healing: comparison with platelet-rich plasma and potential use in cell culture. Wound Rep Reg 15:511-520.
30. Nissen LJ, R Cao, EM Hedlund, Z Wang, X Zhao, D Wetterskog, K Funa, E Brakenhielm and Y Cao. (2007). Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest 117:2766-2777.
31. Miranville A, C Heeschen, C Sengenes, CA Curat, R Busse and A Bouloumie. (2004). Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110:349-355.
32. Planat-Benard V, JS Silvestre, B Cousin, M Andre, M Nibbelink, R Tamarat, M Clergue, C Manneville, C Saillan-Barreau, M Duriez, A Tedgui, B Levy, L Penicaud and L Casteilla. (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109:656-663.
33. Rehman J, D Traktuev, J Li, S Merfeld-Clauss, CJ Temm-Grove, JE Bobenkerk, CL Pell, BH Johnstone, RV Considine and KL March. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109:1292-1298.
34. Asahara T, T Murohara, A Sullivan, M Silver, R van der Zee, T Li, B Witzenbichler, G Schatteman and JM Isner. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
35. Mifune Y, T Mastumoto, A Kawamoto, R Kuroda, T Shoji, H Iwasaki, SM Kwon, M Miwa, M Kurosaka and T Asahara. (2008). Local delivery of granulocyte colony stimulating factormobilized CD34-positive progenitor cells using bioscaffold for modality of unhealing bone fracture. Stem Cells 26:1395-1405.
36. Zengin E, F Chalajour, UM Gehling, WD Ito, H Treede, H Lauke, J Weil, H Reichenspurner, N Kilic and S Ergun. (2006). Vascular wall resident progenitor cells: A source for postnatal vasculogenesis. Development 133:1543-1551.
37. Thangarajah H, IN Via, E Chang, S El-Ftesi, M Januszyk, EI Chang, J Paterno, E Neofytou, MT Longaker and GC Gurtner. (2009). IFATS collection: Adipose stromal cells adopt a proangiogenic phenotype under the infl uence of hypoxia. Stem Cells 27:266-274.